STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

GKOS insider plans 315-share common stock sale under Form 144

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of GKOS filed a Form 144 indicating an intent to sell 315 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. The shares have an aggregate market value of 33,075.00 based on the information provided, with the sale targeted for 11/25/2025. These 315 shares came from restricted stock that vested on 04/01/2025 and were received as compensation from the issuer on that date. The filing notes that there were 57,434,740 shares outstanding of the same class of common stock, providing context for the size of this planned sale.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many GKOS shares are covered by this Form 144 notice?

The Form 144 covers the planned sale of 315 shares of common stock, listed with an aggregate market value of 33,075.00.

On which exchange and through which broker will the 315 GKOS shares be sold?

The 315 common shares are indicated to be sold on the NYSE through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.

What is the planned sale date for the 315 GKOS shares in this Form 144?

The filing lists an approximate date of sale of 11/25/2025 for the 315 common shares covered by the notice.

How were the 315 GKOS shares being sold under Form 144 originally acquired?

The 315 common shares were acquired on 04/01/2025 through restricted stock vesting from the issuer, with the nature of payment described as compensation.

How many GKOS common shares are outstanding compared to the 315-share sale?

The notice states that there are 57,434,740 common shares outstanding, providing context relative to the 315 shares planned for sale.

Does the Form 144 filing include any representation about undisclosed adverse information?

Yes. By signing the notice, the seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, as required by the form language.

Glaukos Corp

NYSE:GKOS

GKOS Rankings

GKOS Latest News

GKOS Latest SEC Filings

GKOS Stock Data

6.05B
55.54M
3.31%
107.34%
5.9%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALISO VIEJO